跳至主要内容
临床试验/NCT02863276
NCT02863276已完成不适用

Modulating the Stress Response in Diabetes Mellitus Type 2 Patients Undergoing Colon Surgery

University Hospital, Basel, Switzerland0 个研究点目标入组 18 人开始时间: 2009年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
主要终点
Postoperative protein balance (leucine) (umol/kg/h)

研究概览

简要总结

Background Surgical injury provokes a stress response. These pathways mediated by stress hormones and cytokines cause a catabolic state. The loss of body cell mass may result in prolonged convalescence and increased morbidity. Protein catabolism after colorectal surgery is even more increased in patients with type 2 diabetes mellitus. Epidural blockade, by reducing the intensity of the catabolic response, improves substrate utilization after surgery in non-diabetic patients. This effect is even more pronounced in diabetic patients receiving amino acids.

The aim of the study is to explore the effect of two different protocols to manage blood glucose control on glucose and protein metabolism in patients with type 2 diabetes mellitus undergoing colon surgery and receiving epidural analgesia and perioperative feeding with amino acids. The following hypotheses are tested:

  1. Tight perioperative blood glucose control with intensified insulin therapy compared to standard blood glucose control in presence of general anesthesia with epidural analgesia and amino acid infusion would reduce endogenous glucose production and leucine oxidation.
  2. Tight blood glucose control and perioperative infusion of amino acids induce a more positive protein balance compared to standard blood glucose control by better oxidative glucose utilization and redirecting amino acids from oxidative to synthetic pathways.

Material and Methods A total of 20 patients with diabetes mellitus type 2 undergoing elective colorectal surgery will be admitted to the study. Patients will be randomly assigned to receive standard blood glucose control (blood glucose target <10 mmol*l-1; control group; cytotoxic T lymphocyte (CTL) group, n=8) or to receive tight blood glucose control with intensified insulin therapy (blood glucose target<6 mmol*l-1; intensified insulin group; II group, n=8). All patients will receive general anesthesia and an epidural catheter for perioperative analgesia. During surgery (intraoperative state) and immediately after surgery (postoperative state) when receiving an amino acid infusion protein and glucose kinetics will be assessed using a stable isotope technique with L-[1-13C]leucine and [6,6-2H2]glucose and circulating concentrations of glucose, glucagon, insulin and cortisol will be measured. The primary endpoints of the study will be protein balance. Sample size is set to ensure at least 80% power at a significance level of 0.05.

详细描述

see information below

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients undergoing elective colorectal surgery for non-metastatic disease
  • •Type 2 diabetes mellitus with plasma level of glycosylated hemoglobin level (HbA(1c)) less than 10% indicating normal or moderate glycemic control
  • •Being capable of signing informed consent
  • •Accepting an epidural catheter for perioperative analgesia

排除标准

  • •American Society of Anesthesiologists (ASA) Physical Status classification system 4 with major cardiac disorders (severe arrhythmias, recent myocardial ischemia (MI), heart failure, uncontrolled hypertension)
  • •Hepatic disorders (liver failure, jaundice, metastatic disease), renal disorders (acute or chronic renal failure or on dialysis)
  • •Metabolic disorders (untreated hyperthyroidism, pyrexia, more than 10% weight loss over the preceding three months, plasma albumin concentration < 35g/l)
  • •Anemia (hemoglobin < 10 g/dl)
  • •Chemotherapy or radiotherapy during six months before surgery
  • •Inflammatory bowel disease or other inflammatory condition
  • •Pregnancy
  • •Previous spine surgery precluding placement of an epidural catheter.

研究组 & 干预措施

Intensified insulin group

Experimental

Patients undergoing elective colorectal surgery will receive standard anesthesia including epidural analgesia and nutritional support with an intravenous amino acid solution while receiving tight blood glucose control with intensified insulin therapy (blood glucose target<6 mmol*l-1) via an continuous insulin infusion.

干预措施: Intensified insulin therapy (Procedure)

Control group

No Intervention

Patients undergoing elective colorectal surgery will receive standard anesthesia including epidural analgesia and nutritional support with an intravenous amino acid solution while receiving standard blood glucose control (blood glucose target <10 mmol*l-1) via subcutaneous insulin boluses

结局指标

主要结局

Postoperative protein balance (leucine) (umol/kg/h)

时间窗: Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours

Measured and calculated with a 3-hour stable isotope tracer technique with L-(1-13C)leucine and calorimetry towards the end of the 3 hour period

次要结局

  • Intraoperative glucose metabolism: Glucose clearance (ml/kg/min)(Intraoperative period: starting with the induction of anesthesia and ending after 3 hours (during surgery))
  • Postoperative protein metabolism: Rate of appearance of leucine (umol/kg/h)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)
  • Postoperative protein metabolism: Endogenous rate of appearance of leucine (umol/kg/h)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)
  • Intraoperative protein metabolism: Rate of appearance of leucine (umol/kg/h)(Intraoperative period: starting with the induction of anesthesia and ending after 3 hours (during surgery))
  • Intraoperative protein metabolism: endogenous rate of appearance of leucine (umol/kg/h)(Intraoperative period: starting with the induction of anesthesia and ending after 3 hours (during surgery))
  • Postoperative protein metabolism: Protein synthesis (leucine) (umol/kg/h)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)
  • Postoperative glucose metabolism: Endogenous rate of appearance of glucose (umol/kg/min)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)
  • Intraoperative glucose metabolism: Endogenous rate of appearance of glucose (umol/kg/min)(Intraoperative period: starting with the induction of anesthesia and ending after 3 hours (during surgery))
  • Postoperative protein metabolism: Leucine oxidation (umol/kg/h)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)
  • Postoperative glucose metabolism: Glucose clearance (ml/kg/min)(Postoperative period: starting with arrival in the postoperative care unit and ending after 3 hours)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

相似试验